Skip to content

Clinical trials

Phase 2/3 Sudden Infant Death trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sudden Infant Death Phase: Phase 2/3 Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20081
20141
20181
20211
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting3
Completed3
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shire3
Denali Therapeutics Inc.2
AO GENERIUM1
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center1
REGENXBIO Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mucopolysaccharidosis II8
Sudden Infant Death8
Lysosomal Storage Diseases4
Cognition Disorders1
Cognitive Dysfunction1
Connective Tissue Diseases1
Dwarfism1
Genetic Diseases, Inborn1
Genetic Diseases, X-Linked1
Heredodegenerative Disorders, Nervous System1

Trials

Showing 51 to 8 of 8. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.